Fact CheckerSign in

NCT07402980Completed

Development of the Polycystic Ovary Syndrome Symptoms Inventory

Polycystic Ovary Syndrome Symptoms Inventory: Development, Validity and Reliability in Turkey

Source: ClinicalTrials.gov · Last updated 23 Feb 2026

Brief summary (registry, in English)

Polycystic Ovary Syndrome Symptom Severity and Distress Inventory: Development, Validity and Reliability in Turkey The goal of this observational study is to develop and validate a self-report inventory that assesses Polycystic Ovary Syndrome (PCOS) symptoms and the level of distress experienced by women diagnosed with PCOS. The main question it aims to answer is: Is the newly developed inventory a valid and reliable instrument for assessing PCOS symptoms and related distress in women? Participants will answer online survey questions including a demographic information form and three scales evaluating psychological health and PCOS related symptoms, including the newly developed symptom and distress inventory.

Status (registry)
Completed
Study type
Observational
Enrollment
227 (actual)
First submitted
5 Feb 2026
Start date
1 Oct 2025
Primary completion date
15 Feb 2026
Lead sponsor
Abant Izzet Baysal University
NCT number
NCT07402980

What you commit to

  • Study type: Observational
  • Participants enrolled: 227
  • From 1 Oct 2025 to the primary completion date, 15 Feb 2026
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • Having a disease that could cause symptoms similar to PCOS (such as Cushing's syndrome, thyroid dysfunction, hyperprolactinemia, androgen-secreting tumors)

Who the study is looking for

  • Being a woman aged 18-49 (of reproductive age) who states she has been diagnosed with PCOS
  • Being able to read and understand Turkish
  • Volunteering to participate in the study

Age in the registry: 18 years to 49 years · Sex: Female · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Bolu Abant Izzet Baysal University
Coordinator of this site? Confirm its status
BoluTurkey (Türkiye)Unknown status

This page is information, not medical advice. Discuss any trial with your doctor.